Ugo Trama

1.3k total citations
82 papers, 574 citations indexed

About

Ugo Trama is a scholar working on Infectious Diseases, Epidemiology and Pharmacology. According to data from OpenAlex, Ugo Trama has authored 82 papers receiving a total of 574 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Infectious Diseases, 14 papers in Epidemiology and 11 papers in Pharmacology. Recurrent topics in Ugo Trama's work include COVID-19 Clinical Research Studies (14 papers), SARS-CoV-2 and COVID-19 Research (13 papers) and Long-Term Effects of COVID-19 (9 papers). Ugo Trama is often cited by papers focused on COVID-19 Clinical Research Studies (14 papers), SARS-CoV-2 and COVID-19 Research (13 papers) and Long-Term Effects of COVID-19 (9 papers). Ugo Trama collaborates with scholars based in Italy, United States and Spain. Ugo Trama's co-authors include Valentina Orlando, Enrica Menditto, Sara Mucherino, Francesco Ferrara, Andrea Zovi, Antonio Vitiello, Eduardo Nava, Francesca Futura Bernardi, Enrico Coscioni and Annalisa Capuano and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Ugo Trama

72 papers receiving 565 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ugo Trama Italy 13 133 93 66 60 52 82 574
Lahcen Belyamani Morocco 13 112 0.8× 46 0.5× 35 0.5× 26 0.4× 21 0.4× 114 539
Rodolfo Sbrojavacca Italy 12 57 0.4× 80 0.9× 31 0.5× 72 1.2× 16 0.3× 24 386
Nathalie Zappella France 12 142 1.1× 171 1.8× 44 0.7× 12 0.2× 14 0.3× 37 636
Glen Brown Canada 16 73 0.5× 176 1.9× 19 0.3× 134 2.2× 29 0.6× 46 706
Thyago Proença de Moraes Brazil 19 51 0.4× 91 1.0× 13 0.2× 41 0.7× 53 1.0× 86 1.5k
Afzal Azim India 18 88 0.7× 231 2.5× 38 0.6× 20 0.3× 39 0.8× 96 1.0k
Dimitrios Lathyris Greece 16 33 0.2× 233 2.5× 51 0.8× 34 0.6× 38 0.7× 18 1.3k
Ulrich Jaschinski Germany 13 44 0.3× 375 4.0× 30 0.5× 39 0.7× 19 0.4× 20 688
André Luís Balbi Brazil 25 133 1.0× 199 2.1× 57 0.9× 164 2.7× 11 0.2× 112 2.0k
João Manoel Silva Brazil 18 60 0.5× 265 2.8× 64 1.0× 50 0.8× 19 0.4× 96 1.0k

Countries citing papers authored by Ugo Trama

Since Specialization
Citations

This map shows the geographic impact of Ugo Trama's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ugo Trama with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ugo Trama more than expected).

Fields of papers citing papers by Ugo Trama

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ugo Trama. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ugo Trama. The network helps show where Ugo Trama may publish in the future.

Co-authorship network of co-authors of Ugo Trama

This figure shows the co-authorship network connecting the top 25 collaborators of Ugo Trama. A scholar is included among the top collaborators of Ugo Trama based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ugo Trama. Ugo Trama is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Benincasa, Giuditta, Paola Bontempo, Ugo Trama, & Claudio Napoli. (2025). Synergistic Effects of a Novel Combination of Natural Compounds Prevent H2O2-Induced Oxidative Stress in Red Blood Cells. International Journal of Molecular Sciences. 26(3). 1334–1334.
2.
Sorrentino, Michele, Michelangelo Mercogliano, Vincenzo Giordano, et al.. (2025). The structural and organizational aspects of human papillomavirus vaccine affecting immunization coverage in Europe: a systematic review. BMC Public Health. 25(1). 1254–1254. 2 indexed citations
3.
Mucherino, Sara, Annunziata Raimondo, Ignacio Aznar‐Lou, et al.. (2025). Drug Utilization and Medication Adherence: A Data-Driven Analysis of Drugs with Different Routes of Administration Applied in Atopic Dermatitis. Pharmaceutics. 17(10). 1279–1279.
4.
Rosa, Elvira De, et al.. (2025). Contamination assessment and risk evaluation of organophosphorus pesticides in groundwater: A study on contamination patterns and implications. Journal of Hazardous Materials Advances. 18. 100701–100701.
5.
Ferrara, Francesco, et al.. (2024). Antibacterial agents and the fight against antibiotic resistance: A real-world evidence analysis of consumption and spending by an Italian healthcare company. Annales Pharmaceutiques Françaises. 82(3). 545–552. 5 indexed citations
6.
Trimarco, Valentina, Raffaele Izzo, Daniela Pacella, et al.. (2024). Incidence of new-onset hypertension before, during, and after the COVID-19 pandemic: a 7-year longitudinal cohort study in a large population. BMC Medicine. 22(1). 127–127. 23 indexed citations
7.
Ferrara, Francesco, et al.. (2024). Comparison and Analysis of Antibiotic Consumption in Two Italian Hospital Settings in Relation to the Fight of Antimicrobial Resistance. Pharmaceuticals. 17(2). 183–183. 3 indexed citations
8.
Ferrara, Francesco, Andrea Zovi, Eduardo Nava, Ugo Trama, & Antonio Vitiello. (2023). SARS-CoV-2 caused a surge in antibiotic consumption causing a silent pandemic inside the pandemic. A retrospective analysis of Italian data in the first half of 2022. Annales Pharmaceutiques Françaises. 81(4). 627–635. 12 indexed citations
9.
Montuori, Paolo, Claudio Fiorilla, Michele Sorrentino, et al.. (2023). Understanding Factors Contributing to Vaccine Hesitancy in a Large Metropolitan Area. Vaccines. 11(10). 1558–1558. 9 indexed citations
10.
Mascolo, Annamaria, Ugo Trama, Liberata Sportiello, et al.. (2023). Thromboembolic Events after COVID-19 Vaccination: An Italian Retrospective Real-World Safety Study. Vaccines. 11(10). 1575–1575.
11.
Ferrara, Francesco, et al.. (2023). Sustainability and evolution of health care regarding treatments concerning type 2 diabetes mellitus. Ethics Medicine and Public Health. 28. 100890–100890. 1 indexed citations
12.
Montuori, Paolo, Michele Sorrentino, Francesca Pennino, et al.. (2023). Assessment on Practicing Correct Body Posture and Determinant Analyses in a Large Population of a Metropolitan Area. Behavioral Sciences. 13(2). 144–144. 4 indexed citations
13.
Ferrara, Francesco, et al.. (2023). Il contrasto dell’antibiotico-resistenza: serve una nuova linea di azione. Recenti Progressi in Medicina. 114(5). 277–283. 5 indexed citations
14.
Montuori, Paolo, et al.. (2023). Health Risk Assessment of PAHs from Estuarine Sediments in the South of Italy. Toxics. 11(2). 172–172. 13 indexed citations
16.
Vitiello, Antonio, et al.. (2022). Pleiotropic effects of AT-1 receptor antagonists in hypoxia induced by cardiac ischaemia. Inflammopharmacology. 30(4). 1407–1410. 1 indexed citations
17.
Ferrara, Francesco, Andrea Zovi, Eduardo Nava, et al.. (2022). COVID-19 mRNA Vaccines: A Retrospective Observational Pharmacovigilance Study. Clinical Drug Investigation. 42(12). 1065–1074. 11 indexed citations
18.
Orlando, Valentina, et al.. (2020). Treatment patterns and medication adherence among newly diagnosed patients with migraine: a drug utilisation study. BMJ Open. 10(11). e038972–e038972. 22 indexed citations
19.
Maniscalco, Giorgia Teresa, Vincenzo Brescia Morra, Ciro Florio, et al.. (2020). Preliminary Results of the FASM Study, an On-Going Italian Active Pharmacovigilance Project. Pharmaceuticals. 13(12). 466–466. 7 indexed citations
20.
Trama, Ugo, et al.. (1976). Verdi's Falstaff. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026